Pharma Sci 2021
Pharma Sci 2021
The most anticipated Pharma event in the world and you're welcome to attend 21st World Congress on Advances in Pharmaceutical Sciences scheduled during March 22-23, 2021 through webinar. which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This strategic conference will provide in-depth presentations and interactive sessions, for the possibility to network with like-minded professionals and discuss how to overcome the current challenges in pharmaceutical product synthesis and product development. The focus this year will be on the latest advancements, research and development to inspect the challenges in Pharmaceutical Sciences, Clinical Research and related areas. Pharma Sci 2021 is a specially designed cluster of all Pharma conferences. The main theme of this Pharma conference is “Advances and researches in Pharmaceutical Sciences” which covers a wide range of critically important sessions.
At Pharma Sci 2021 meet your target audiences from around the world focused on learning about Pharma and Pharma regulations, licenses, approvals. This conference would be your single best opportunity to reach the largest assemblage of participants from the Pharma field.
Over 50+ organizations and international companies will be exhibiting at the Pharma Sci 2021 conference. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.
In addition to the products and services you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.
- Directors, CEO’s of Organizations
- Business Development Managers
- Chief Scientific Officers
- R&D Researchers from Pharma Industries
- Professors, Associate Professors, Assistant Professors
- PhD Scholars
- Patent Attorneys
- Investment Analysts
- Association, Association presidents and professionals
- Noble laureates in Health Care and Medicine
- Bio instruments Professionals
- Bio-informatics Professionals
- Software development companies
- Research Institutes and members
- Supply Chain companies
- Manufacturing Companies
- CRO and DATA management Companies
- Training Institutes
- Business Entrepreneurs
Pharma Sci 2021 Tracks
Track:1 Pharmaceutical Nanotechnology
Nanotechnology is manipulation of matter on an atomic, molecular, and supramolecular scale. The earliest, widespread description of nanotechnology referred to the particular technological goal of precisely manipulating atoms and molecules for fabrication of macroscale products, also now referred to as molecular nanotechnology. A more generalized description of nanotechnology was subsequently established by the National Nanotechnology Initiative, which defines nanotechnology as the manipulation of matter with at least one dimension sized from 1 to 100 nanometers. This definition reflects the fact that quantum mechanical effects are important at this quantum-realm scale, and so the definition shifted from a particular technological goal to a research category inclusive of all types of research and technologies that deal with the special properties of matter which occur below the given size threshold. It is therefore common to see the plural form "nanotechnologies" as well as "nanoscale technologies" to refer to the broad range of research and applications whose common trait is size.
Track 2: Pharmaceutical Science Developments
The pharmaceutical sciences combine a broad range of scientific disciplines that are critical to the discovery and development of new drugs and therapies. Pharmaceutical sciences can be broadly classified into the following main categories, with many specialized fields within each category.
Over the years, pharmaceutical scientists have been instrumental in discovering and developing innovative drugs that save thousands of people’s lives and improve the quality of life for many others. Pharmaceutical scientists can pursue a variety of jobs. They are employed by pharmaceutical companies, they work as pharmacists, doctors, and as researchers and professors at universities, as regulatory scientists for agencies like the Food and Drug Administration (FDA), and as researchers at national laboratories such as the National Institutes of Health (NIH).
The branch of genetics concerned with determining the likely response of an individual to therapeutic drugs. Its name reflects it’s combining of pharmacology and genomics. It deals with the influences such as acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics and pharmacodynamics (drug absorption, distribution, metabolism, and elimination), as well as drug receptor target effects.
WHO is gathering the latest international multilingual scientific findings and knowledge on COVID-19. The global literature cited in the WHO COVID-19 database is updated daily (Monday through Friday) from searches of bibliographic databases, hand searching, and the addition of other expert-referred scientific articles. This database represents a comprehensive multilingual source of current literature on the topic. While it may not be exhaustive, new research is added regularly.
Clinical Sciences are concerned with the use of drugs in the treatment of diseases. Properties of new drugs — such as efficacy, adverse effects, drug-to-drug interaction, bioavailability — are determined in clinical trials in humans.
Track: 6 Nano Drug Delivery Technologies
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.
Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. As such, pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation). Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.
Track: 8 Advances in Healthcare
Healthcare is the maintenance or improvement of health via the prevention, diagnosis, and treatment of disease, illness, injury, and other physical and mental impairments in people. Health care is delivered by health professionals in allied health fields. Physicians and physician associates are a part of these health professionals. Dentistry, midwifery, nursing, medicine, optometry, audiology, pharmacy, psychology, occupational therapy, physical therapy and other health professions are all part of health care. It includes work done in providing primary care, secondary care, and tertiary care, as well as in public health.
Track: 9 Computer Applications in Pharmacy
Computers are now a days used in pharmaceutical in industries, hospitals and in various departments for drug information, education, evaluation, analysis, medication history and for maintenance of financial records. They have become indispensable in the development of clinical pharmacy, hospital pharmacy and pharmaceutical research. Computers are also useful for patient profile monitoring, medication, database management and material management. It is useful in providing on drug interactions, drug information services and patient counseling.
Track: 10 Good Manufacturing Practices
Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product.
GMP covers all aspects of production from the starting materials, premises, and equipment to the training and personal hygiene of staff. Detailed written procedures are essential for each process that could affect the quality of the finished product. There must be systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process - every time a product is made.
Pharmaceutical Sciences is a stimulating field as it links many scientific disciplines and allows for collaboration with other scientists in researching and developing new drugs. Medicinal chemists apply their chemistry training to the process of synthesizing new pharmaceuticals. They also improve the processes by which existing pharmaceuticals are made. Medicinal chemists are focused on drug discovery and development and are concerned with the isolation of medicinal agents found in plants, as well as the creation of new synthetic drug compounds.
Chemistry volumes continue to rise in the U.S. and chemical market expected to contract this year—As a result, chemical industry capital spending in the U.S. surged 12.1% in 2014 and gained 21.0% in 2015, reaching $43.58 billion and accounting for more than one-half of total construction spending by the manufacturing sector. The association representing US-based chemical producers said that US chemical production (excluding pharmaceuticals) is expected to realize the overall growth of 1.6% in 2016, followed by 4.1% growth next year, and 5.0% in 2018. Average annual gains of over 8% per year in U.S. Chemical industry capital spending are expected through 2018 with only a minor slowdown in subsequent growth expected. By 2022, ACC expects capital spending to reach $70 billion, contributing to four consecutive years of job growth in the industry. American chemistry revenues will exceed $1.0 trillion by 2022.
Chemistry Council stated that more than 275 new chemical production projects had been announced since 2010 with a total value of more than $170 billion, with a full 49% already complete or under construction; 61% of these are the foreign direct investment. By 2021, U.S. capital spending by the chemical industry will reach $65 billion—more than triple the level of spending at the start of this prolonged cycle in 2010. The trade surplus in chemicals (excluding pharmaceuticals) will grow to $36 billion this year as exports rise by 2% to $132 billion and imports hold steady at $96 billion. Two-way trade between the U.S. and its foreign partners will reach $227 billion this year and will grow steadily over the coming years.
The popularity of Formulation and Drug Discovery has increased significantly in recent years. The Drug Delivery Technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Drug delivery technology market offers a promising approach for the delivery of various kinds of drugs that have different molecular formulation. Drug delivery technology is aimed at maximizing the drug delivery at the targeted site so as to increase the efficiency of drug and proposing improved patient compliance.
Past Conference Report
All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.
Abstracts will be provided with Digital Object Identifier by